Cindy Massari, a 69-year-old grandmother from New Jersey, experienced the unimaginable journey of battling breast cancer not once, but twice. First diagnosed with stage 1 breast cancer in 2012 following a routine mammogram, Massari believed she had overcome the worst. The diagnosis indicated a non-aggressive form of cancer, prompting her to undergo a lumpectomy, radiation therapy, and hormone treatment. “I thought I could start living happily ever after,” she recalled in a recent interview.
:max_bytes(150000):strip_icc():format(jpeg)/Cindy-Massari-100726-5-118af8deaca74becb7bac067bc422c46.jpg)
However, in a shocking turn of events five years later, Massari received devastating news: she had been diagnosed with stage 4 metastatic breast cancer. The moment her husband, Ronald, also a physician, informed her of the diagnosis, her heart sank. “I had just welcomed my first grandchild, and my immediate thought was that I might never see him grow up,” she reflected.
Prior to the diagnosis, Massari experienced troubling symptoms, including a persistent tickle in her throat and a cough that refused to subside. It was not until she felt breathless while walking at the hospital where she worked as a registered nurse that she realised something was seriously amiss. Thanks to her position, she was able to arrange for an immediate chest X-ray, which, upon review, indicated concerning abnormalities. A subsequent CAT scan confirmed the presence of small nodules in her lungs, leading to a thoracotomy, a surgical procedure to investigate further.
When Massari opened her eyes post-surgery, the sight of emotional nursing staff, who she had worked alongside for years, made the gravity of her illness hit harder. “When I woke up and saw them crying, I knew it was serious,” she explained. It was then that Ronald confirmed her worst fears: her cancer had metastasised, and grief engulfed her.
The National Cancer Institute reports that a concerning 20% to 30% of women initially diagnosed with early-stage breast cancer develop metastatic cases later in their lives. Treatment options for this advanced stage usually include a combination of hormone therapy, chemotherapy, immunotherapy, and targeted therapies. The five-year survival rate currently stands at around 32%, although advancements in treatment have raised hopes for patients and clinicians alike.
Dr. Seth Wander, from the Breast Oncology Program at Mass General Brigham Cancer Institute, highlighted positive developments in the field, noting that the survival metrics are evolving significantly. “With new drugs emerging and ongoing research, we expect to see meaningful changes in outcomes for patients in the coming years,” he said, providing a glimmer of optimism amidst the dire diagnosis.
Massari has been proactive in managing her condition, opting for an oral medication and currently displaying no evidence of the disease. Reflecting on her journey, she has chosen to focus on advocacy for herself, seeking second opinions, and remaining abreast of medical literature. “I made the conscious choice to stay positive for my family,” she emphasised. “I want to be present in their lives, and they in mine.”
Fortunately, time has been a surprising ally. What once felt heartbreaking has transformed into a source of joy. Massari’s grandson, who she feared she would never see grow beyond infancy, has celebrated his ninth birthday. “I feel incredibly blessed to have been able to witness his growth,” she said. “He has become one of the greatest gifts in my life, reminding me to live each day to the fullest.”
Her resilience and determination to move beyond grief showcase an inspiring journey of hope. “I never anticipated I could possess such strength,” she concluded, highlighting her ability to persevere despite the uncertainties that lie ahead.
Cindy Massari’s story is one of courage amid adversity—a testament to the human spirit’s capacity to endure and thrive, even when faced with life-altering challenges.